Issue 3/2014

miR-155 as a diagnostic and prognostic marker in hematological and solid malignancies (241 — 251)

D. JURKOVICOVA, M. MAGYERKOVA, L. KULCSAR, M. KRIVJANSKA, V. KRIVJANSKY, A. GIBADULINOVA, I. OVECKOVA, M. CHOVANEC

DOI: 10.4149/neo_2014_032

Nesidioblastosis in adults (252 — 256)

I. DRAVECKA, I. LAZUROVA

DOI: 10.4149/neo_2014_047

Impact of Annexin A3 expression in gastric cancer cells (257 — 264)

S. Y. YU, Y. LI, L. Q. FAN, Q. ZHAO, B. B. TAN, Y. LIU

DOI: 10.4149/neo_2014_033

MicroRNA-19b targets Mfn1 to inhibit Mfn1-induced apoptosis in osteosarcoma cells (265 — 273)

X. LI, F. S. WANG, Z. Y. WU, J. L. LIN, W. B. LAN, J. H. LIN

DOI: 10.4149/neo_2014_034

Efficient inhibition of intraperitoneal human ovarian cancer growth by short hairpin RNA targeting CD44 (274 — 282)

L. ZOU, T. YI, X. SONG, S. LI, Y. WEI, X. ZHAO

DOI: 10.4149/neo_2014_035

Intestinal flora of FAP patients containing APC-like sequences (283 — 290)

K. HAINOVA, Z. ADAMCIKOVA, S. CIERNIKOVA, V. STEVURKOVA, S. TYCIAKOVA, V. ZAJAC

DOI: 10.4149/neo_2014_036

ZNF139 promotes tumor metastasis by increasing migration and invasion in human gastric cancer cells (291 — 298)

Y. LI, B. B. TAN, Q. ZHAO, L. Q. FAN, D. WANG, Y. LIU

DOI: 10.4149/neo_2014_037

Management and results of treatment of breast cancer patients having sentinel lymph node micrometastases (299 — 304)

T. NOWIKIEWICZ, E. SRUTEK, M. JANKOWSKI, M. LAS-JANKOWSKA, M. KLAG, D. KOZAK, I. GLOWACKA, W. ZEGARSKI

DOI: 10.4149/neo_2014_038

Primary cilia in gastrointestinal stromal tumors (305 — 308)

J. DVORAK, V. SITOROVA, D. HADZI NIKOLOV, A. FILIPOVA, A. RYSKA, B. MELICHAR, I. RICHTER, D. BUKA, J. MOKRY, S. FILIP, J. PETERA

DOI: 10.4149/neo_2014_039

Platelet-activating factor (PAF) receptor expression is associated with histopathological stage and grade and patients’ survival in gastric adenocarcinoma (309 — 317)

C. GIAGINIS,E. KOUROU, A. GIAGINI, N. GOUTAS, E. PATSOURIS, G. KOURAKLIS, S. THEOCHARIS

DOI: 10.4149/neo_2014_040

DLX4 as a prognostic marker for hepatocellular carcinoma (318 — 323)

Y. GAO, Z. LI, X. GUO, Y. LIU, K. ZHANG

DOI: 10.4149/neo_2014_041

Pathological analysis of extracapsular extension of metastatic lymph node and its potential impact on nodal clinical target volume in the radiotherapy of esophageal squamous cell carcinoma (324 — 330)

Z. W. WANG, W. ZHANG, W. DONG, B. S. LI, D. B. MU, W. HUANG, J. ZHANG, H. S. LI, Z. C. ZHANG, H. Q. LIN, Y. YI

DOI: 10.4149/neo_2014_042

The biological markers and results of treatment in male breast cancer patients. The Cracow experience. (331 — 339)

B. SAS-KORCZYNSKA, J. NIEMIEC, A. HARAZIN-LECHOWSKA, S. KORZENIOWSKI, D. MARTYNOW, A. ADAMCZYK, A. SOKOLOWSKI

DOI: 10.4149/neo_2014_043

Update meta-analysis on 1790G/A polymorphism and cancer risk: Evidence from 26 studies (340 — 351)

P. LIU, H. SHI, Y. YANG, R. LIU, C. HUANG, H. SHU, J. LI, Q. CHEN, Y. YANG, M. CAI

DOI: 10.4149/neo_2014_044

Association of aldehyde dehydrogenase 1 expression and biologically aggressive features in breast cancer (352 — 362)

E. J. KANG, H. JUNG, O. H. WOO, K. H. PARK, S. U. WOO, D. S. YANG, A. R. KIM, J. B. LEE, Y. H. KIM, J. S. KIM, J. H. SEO

DOI: 10.4149/neo_2014_045